Cargando…
Cardiovascular outcomes associated with treatment of type 2 diabetes in patients with ischaemic heart failure
AIM: The optimal strategy for diabetes control in patients with heart failure (HF) following myocardial infarction (MI) remains unknown. Metformin, a guideline‐recommended therapy for patients with chronic HF and type 2 diabetes mellitus (T2DM), is associated with reduced mortality and HF hospitaliz...
Autores principales: | Godec, Thomas R., Bromage, Daniel I., Pujades‐Rodriguez, Mar, Cannatà, Antonio, Gonzalez‐Izquierdo, Arturo, Denaxas, Spiros, Hemingway, Harry, Shah, Ajay M., Yellon, Derek M., McDonagh, Theresa A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9065866/ https://www.ncbi.nlm.nih.gov/pubmed/35322592 http://dx.doi.org/10.1002/ehf2.13910 |
Ejemplares similares
-
Metformin use and cardiovascular outcomes after acute myocardial infarction in patients with type 2 diabetes: a cohort study
por: Bromage, Daniel I., et al.
Publicado: (2019) -
The impact of COVID‐19 on heart failure hospitalization and management: report from a Heart Failure Unit in London during the peak of the pandemic
por: Bromage, Daniel I., et al.
Publicado: (2020) -
Treatment of Iron Deficiency in Heart Failure
por: Shamsi, Aamir, et al.
Publicado: (2023) -
How Does Cardiovascular Disease First Present in Women and Men?: Incidence of 12 Cardiovascular Diseases in a Contemporary Cohort of 1 937 360 People
por: George, Julie, et al.
Publicado: (2015) -
Ethnicity and the first diagnosis of a wide range of cardiovascular diseases: Associations in a linked electronic health record cohort of 1 million patients
por: George, Julie, et al.
Publicado: (2017)